Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Kala Pharmaceuticals Inc. (KALA)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
RA Capital Management

Peter Kolchinsky

2,113,236 $20,858 1.11%
2.
Broadfin Capital

Kevin Kotler

346,083 $3,416 -43% 0.5%
3.
OrbiMed Advisors

Samuel Isaly

3,447,840 $34,030 0.4%
4.
Millennium Management

Israel Englander

392,642 $3,875 -35% 0%
5.
D E Shaw

D. E. Shaw

21,804 $215 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$8.25 606,060 Director 2,877,006 2018-10-05 Filing
$8.25 2,424,242 Large Shareholder, Director 4,537,478 2018-10-03 Filing
$8.25 2,424,242 Large Shareholder, Director 4,537,478 2018-10-03 Filing
$12.93 25,000 Large Shareholder 3,447,840 2018-02-08 Filing
$14.73 37,840 Large Shareholder 3,422,840 2018-02-02 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 1,857,582 $18,334 9.17%
2. 199,613 $1,970 1.38%
3. 61,000 $602 1.18%
4. 1,043,020 $10,295 1.03%
5. 99,186 $955 0.86%